Division of Cardiology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Division of Cardiology, Università della Svizzera Italiana and Istituto Cardiocentro Ticino, Lugano, Switzerland.
Europace. 2023 Aug 25;25(8). doi: 10.1093/europace/euad168.
Cardiac resynchronization therapy (CRT) was proposed in the 1990s as a new therapy for patients with heart failure and wide QRS with depressed left ventricular ejection fraction despite optimal medical treatment. This review is aimed first to describe the rationale and the physiologic effects of CRT. The journey of the landmark randomized trials leading to the adoption of CRT in the guidelines since 2005 is also reported showing the high level of evidence for CRT. Different alternative pacing modalities of CRT to conventional left ventricular pacing through the coronary sinus have been proposed to increase the response rate to CRT such as multisite pacing and endocardial pacing. A new emerging alternative technique to conventional biventricular pacing, conduction system pacing (CSP), is a promising therapy. The different modalities of CSP are described (Hirs pacing and left bundle branch area pacing). This new technique has to be evaluated in clinical randomized trials before implementation in the guidelines with a high level of evidence.
心脏再同步治疗(CRT)于 20 世纪 90 年代提出,作为心力衰竭和宽 QRS 波并伴有左心室射血分数降低的患者的一种新的治疗方法,尽管进行了最佳的药物治疗。本篇综述旨在首先描述 CRT 的基本原理和生理效应。报告了自 2005 年以来,导致 CRT 被纳入指南的里程碑式随机试验的历程,表明 CRT 具有很高的证据水平。为了提高 CRT 的反应率,已经提出了 CRT 的不同替代起搏模式,通过冠状窦进行传统的左心室起搏,如多点起搏和心内膜起搏。一种新的替代传统双心室起搏的新兴技术,即心脏传导系统起搏(CSP),是一种很有前途的治疗方法。描述了不同的 CSP 模式(希氏起搏和左束支区域起搏)。在将其纳入指南之前,需要在临床随机试验中评估这种新技术,以获得高证据水平。